Tag Archives: AKBA

Hot Warren Buffett Stocks For 2018

Since 2014 Hershey (NYSE:HSY) has been struggling a lot with its foreign operations. This has been due to the facts that the general business environment has been rather weak in foreign countries where Hershey is operating, that a strong dollar has hurt the sales and especially that the Chinese market has proved to be much more difficult than expected.

One other thing that I am even more worried about is the way the current management at Hershey is using adjusted earnings in its earnings releases. I do not know about the rest of the investors, but at least for me, when management is constantly talking about adjusted earnings instead of actual earnings, it is a warning sign. I can fully understand one-time business costs, such as transactions costs related to a major acquisition. In that type of a situation it is perfectly fine to use adjusted earnings because they give more visibility about the true earnings power of a company. However, when a company starts to constantly categorize regular annual costs as one-time costs, like Hershey is doing with business realignment costs, you should be very worried. In the case of Hershey, I would consider the business realignment costs as regular costs as they have been there for several years. This is a bit like when Warren Buffett is recommending that investors walk away if management is constantly referring to EBIT figures.

Hot Warren Buffett Stocks For 2018: Smithfield Foods Inc.(SFD)

Advisors’ Opinion:

  • [By John Udovich]

    Thanksgiving is almost here but the exit of both Pilgrim’s Pride Corporation (NYSE: PPC) and Smithfield Foods (NYSE: SFD) to focus on their chicken or pork businesses (the latter was also acquired by the Chinese) leaves just two big Thanksgiving turkey stocks, Hormel Foods Corporation (NYSE: HRL) and Seaboard Corporation (NYSEAMEX: SEB), for investors to consider. According to the American Far Bureau, a 16-pound turkey will (on average) come in at a total of $22.74 this year or roughly $1.42 per pound for a decrease of 2 cents per pound or a total of 30 cents per whole turkey, compared to 2015. The price drop may be a transition back to the norm as the significant bird flu outbreak last year hurt the nations supply of both turkey and eggs.

Hot Warren Buffett Stocks For 2018: CarMax Inc(KMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    CarMax, Inc (NYSE: KMX) reported better-than-expected earnings for its fourth quarter.

    CarMax reported Q4 earnings of $0.81 per share on revenue of $4.05 billion. Analysts expected earnings of $0.79 per share on revenue of $3.93 billion.

  • [By Dan Caplinger]

    The car-shopping experience is a much-hated process for many shoppers, and auto seller CarMax (NYSE:KMX) has aimed to change that for the better through a combination of broad vehicle selection and no-hassle sales methods. That approach has given many people positive views of the company, and coming into its fiscal fourth-quarter report on Thursday, CarMax investors had hoped that the approach would pay off in higher sales and profits. CarMax saw particular strength in its used-car market during the quarter, and that helped produce positive momentum that it hopes will persist into the coming fiscal year.

  • [By Chris Lange]

    And CarMax Inc. (NYSE: KMX) is set to report its quarterly results first thing Friday. Analysts are looking for a profit of $0.94 per share and revenue of $4.25 billion. Shares closed most recently at $68.08, in a 52-week range of $47.50 to $69.92 and with a consensus analyst target of $69.13.

  • [By Ben Levisohn]

    CarMax (KMX) soared to the top of the S&P 500 today after the used car retailer beat third-quarter earnings forecasts.

    Getty Images

    CarMaxgained 6.1% to $66.16 today, while the S&P 500 rose 0.4% to 2,270.76.

    As my colleague Johanna Bennett noted earlier today:

    The nations largest used vehicle retailer said that it earned 72 cents a share in the quarter, a penny ahead of analysts estimates. Revenue rose 4.4% year over year to $3.7 billion, just shy of the $3.75 billion consensus estimate.

    CarMax’s market capitalization rose to $12.6 billion today from $11.9 billion yesterday. It reported net income of $623 million on sales of $15.2 billion in fiscal 2016.

Hot Warren Buffett Stocks For 2018: Tata Motors Ltd(TTM)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    I’ve been watching Tata Motors Ltd. (TTM) over the past few years with increasing interest. As India’s largest carmaker, it stands to benefit from the tenfold projected growth in the middle class in both India and China over the next decade.

Hot Warren Buffett Stocks For 2018: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Lisa Levin]

    Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

Hot Warren Buffett Stocks For 2018: First Trust NASDAQ-100- Technology Index Fund(QTEC)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Amazon.com, Inc. (NASDAQ: AMZN): Free Stock Analysis Report
     
    Netflix, Inc. (NASDAQ: NFLX): Free Stock Analysis Report
     
    Facebook, Inc. (NASDAQ: FB): Free Stock Analysis Report
     
    Alphabet Inc. (NASDAQ: GOOGL): Free Stock Analysis Report
     
    Apple Inc. (NASDAQ: AAPL): Free Stock Analysis Report
     
    SPDR-TECH SELS (ETF:XLK): ETF Research Reports
     
    NASDAQ-100 SHRS (NASDAQ: QQQ): ETF Research Reports
     
    SPDR-SP 500 TR (ETF:SPY): ETF Research Reports
     
    PWRSH-DYN SEMI (ETF:PSI): ETF Research Reports
     
    ISHARS-NA TEC-S (ETF:IGV): ETF Research Reports
     
    FIRST N-100 TEC (NASDAQ: QTEC): ETF Research Reports
     
    FT-TECH ALPHA (ETF:FXL): ETF Research Reports
     
    FT-NDQ SEMICON (FTXL): ETF Research Reports
     
    NVIDIA Corporation (NASDAQ: NVDA): Free Stock Analysis Report
     
    Macy's Inc (NYSE: M): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research
     
    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Hot Blue Chip Stocks To Own Right Now

European Pressphoto Agency

An upbeat reading on U.S. retail sales isnt enough to keep U.S. stock indices from tanking today. The Dow dropped more than 200points in late afternoon market action.

The Dow Jones Industrial Average dropped 1.19% and the S&P 500 fell 1% while the Nasdaq Composite fell 0.6%.

Energy and financial shares in the S&P 500 led the declines with the Energy Select Sector SPDR ETF (XLE) and the Financial Select Sector SPDR ETF (XLF) falling 1.5% and 1.3%respectively.

Stock indices have fluctuated severely this week. The Dow posted its biggest gain since March on Tuesday, only to record its worst fall since Feb. 11 the next day. As of now, the blue chip index is poised to record its third straight weekly loss.

Investors are facing a variety of overhangs, from cloudy expectations for corporate earnings to next months Federal Reserve meeting and the UK is poised to vote on whether to exit the European Union.

Hot Blue Chip Stocks To Own Right Now: Sears Holdings Corporation(SHLD)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    Hope is a losing proposition for investors to hold when it comes to the stock market. There is no greater example than with Sears Holding Corp. (Nasdaq: SHLD), the owner of the Sears and Kmart retail store chains.

  • [By Rich Duprey]

    If that’s the case, then it’s reasonable thatSears Holdings (NASDAQ:SHLD) would also join the conga line of companies dumping Trump wares, because despite the bit of life that was recently breathed into its stock following chairman and CEO Eddie Lampert revealing his reorganization plan for the retailer, Sears can’t afford to anger any of its remaining customers.

  • [By Keith Fitz-Gerald]

    Sears Holding Corp. (Nasdaq: SHLD) announced a $900 million deal to sell its iconic Craftsman brand to rival tool maker Stanley Black & Decker earlier this week, leading many investors to wonder if it’s time to pony up for a rebound or just hang on.

  • [By Paul Ausick]

    According to the Financial Times, a total of 13 companies, including Zynga Inc. (NASDAQ: ZNGA) and Sears Holdings Corp. (NASDAQ: SHLD) saw shares rise to $123. For Zynga, that represented a 3,000% boost; for Sears, a 1,000% surge. Four companies, including Amazon and Alphabet Inc. (NASDAQ: GOOGL) fell more than 85% as a result of the glitch.

  • [By Money Morning Staff Reports]

    Shah is keeping his eye on companies like Macy’s Inc. (NYSE: M), JCPenney Co. Inc. (NYSE: JCP), and Sears Holdings Corp. (Nasdaq: SHLD). Though these dead cats may bounce from time to time, their trajectory is decidedly downward.

  • [By Motley Fool Staff]

    In this segment ofIndustry Focus: Consumer Goods, analyst Vincent Shen and contributor Adam Levine-Weinberg turn their attention to several recent initiatives that could help stabilize sales at department stores. They also dig into J.C. Penney’s strategy for profiting from the potential demise of Sears Holdings (NASDAQ:SHLD).

Hot Blue Chip Stocks To Own Right Now: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Lisa Levin]

    Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.

Hot Blue Chip Stocks To Own Right Now: Tableau Software, Inc.(DATA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

Hot Blue Chip Stocks To Own Right Now: Nord Anglia Education, Inc.(NORD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Nord Anglia Education Inc (NASDAQ: NORD) shares shot up 19 percent to $32.83 after the company agreed to be acquired for $32.50 per share in cash.

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested going long on small cap international school stock Nord Anglia Education Inc (NYSE: NORD):

recommended stocks to buy today

In some regards, the election of Donald Trump and the looming implementation of his policies could be a bit confusing for owners of AT&T Inc. (NYSE:T), as well as for owners of Time Warner Inc (NYSE:TWX). But that doesn’t necessarily mean you should shy away from AT&T stock.

Source: Mike Mozart via Flickr

Why are things confusing? Two of Trump’s appointments to his transition team are both staunchly against restrictive regulations within the telecom industry, and are notably anti-net-neutrality.

recommended stocks to buy today: CrossAmerica Partners LP(CAPL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Crossamerica Partners LP (NYSE: CAPL) is projected to report its quarterly earnings at $0.05 per share on revenue of $479.03 million.

    Buckeye Partners, L.P. (NYSE: BPL) is expected to report its quarterly earnings at $1.04 per share on revenue of $1.00 billion.

recommended stocks to buy today: JA Solar Holdings, Co., Ltd.(JASO)

Advisors’ Opinion:

  • [By Spencer Israel]

    Axiom Capital Managing Director Gordon Johnson upgraded the entire alternative energy sector from Market Underweight to Market Overweight and upgraded SolarCity Corp (NASDAQ: SCTY) from Sell to Hold and Trina Solar Limited (ADR) (NYSE: TSL), Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) from Sell to Buy.

  • [By Monica Gerson]

    JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) is estimated to report its quarterly earnings at $0.68 per share on revenue of $683.29 million.

    Leju Holdings Ltd (ADR) (NYSE: LEJU) is projected to report its quarterly earnings at $0.14 per share on revenue of $194.20 million.

  • [By Travis Hoium]

    Earnings season is about over for the solar industry, and after JA Solar (NASDAQ:JASO) and Vivint Solar (NYSE:VSLR) reported this week, there were a few major takeaways from the end of 2016 and early 2017.

  • [By Lisa Levin]

    In trading on Wednesday, energy shares were relative laggards, down on the day by about 0.71 percent. Meanwhile, top losers in the sector included JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO), down 13 percent, and Daqo New Energy Corp (NYSE: DQ) down 8 percent.

  • [By Elizabeth Balboa]

    First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.

  • [By Wayne Duggan] Related JASO Should You Get Rid of JA Solar (JASO) Now? Earnings Scheduled For May 24, 2017
    Related YGE 18 Biggest Mid-Day Losers For Friday 18 Biggest Mid-Day Gainers For Wednesday

    Solar stock investors may have a surprising new ally in Washington. This week, President Donald Trump suggested that his proposed border wall with Mexico could pay for itself if the wall were covered with solar panels.

recommended stocks to buy today: Unilife Corporation(UNIS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Unilife Corp (NASDAQ: UNIS) shares dropped 76 percent to $0.295. Unilife reduced its workforce by 51 employees and expects to record charge of $0.6 million.

recommended stocks to buy today: Medivation Inc.(MDVN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Macro considerations have continued to weigh on stocks whenever they’ve shown signs of life and consensus estimates for many of the large cap companies have been declining. With the sector’s underperformance, the delta in the average PEG ratio for biotech growth companies (excluding Medivation (MDVN)) compared to non-biotech growth companies is slightly wider than it’s been for most of the year. As such, we remain constructive on the sector. That said, while valuations are attractive on a relative basis, there remains some uncertainty for the group and we would not be surprised to see the volatility continue…

  • [By Ben Levisohn]

    Last night, Bloomberg reported that Sanofi (SNY) had made a bid for Medivation (MDVN) but had been rebuffed, while noting that other companies–perhaps Gilead Sciences (GILD), Amgen (AMGN) or AstraZeneca (AZN)?–were also on the prowl. SunTrust Robinson Humphrey’s Peter Lawson explains why Medivation might be biotech’s most wanted:

  • [By Scott Rubin]

    Big gainers on the day included Intersil Corp (NASDAQ: ISIL), which jumped 20 percent on news of a buyout, and Medivation (NASDAQ: MDVN), which added 20 percent on a deal with Pfizer (NYSE: PFE) related to its cancer drug. Cotiviti Holdings Inc (NYSE: COTV) lost around 9 percent in the wake of a mid-day sell-off and Marathon Oil Corporation (NYSE: MRO) fell 7 percent in the wake of a management shakeup.

recommended stocks to buy today: ZAIS Group Holdings, Inc.(ZAIS)

Advisors’ Opinion:

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 42 percent to $3.22. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 48 percent to $3.35. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

recommended stocks to buy today: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

popular stocks to invest in

A Vancouver based mineral exploration company, Nexus Gold focuses its efforts on the worlds most prolific exploration and mining districts. Nexus is currently developing two projects in Burkina Faso, West Africa. Located on the Boromo greenstone belt, the Niangouela gold concession is proximal to the Kalsaka deposit and the Sabce shear.

Nexus Gold is featuring numerous near-surface gold occurrences of both length and grade, as highlighted by historical drill results. Previously explored by Riverstone Resources and Roxgold Inc., the property contains three distinct gold trends, each extending 5 kilometers in length.

The Niangouela gold exploration permit covers 178 square kilometers. To date, a total of 1,173 gold samples have been collected. Nexus Gold completed its initial sampling in December of 2016. This sampling included an 800m Rotary Air Blast (RAB) drill program. These samples returned high-grade mineralization.

popular stocks to invest in: Haynes International, Inc.(HAYN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials sector was the top gainer in the US market on Monday. Top gainers in the sector included Haynes International, Inc. (NASDAQ: HAYN), Cliffs Natural Resources Inc (NYSE: CLF), and Olympic Steel, Inc. (NASDAQ: ZEUS).

  • [By Lisa Levin]

    In trading on Wednesday, basic materials shares fell by 1.24 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 12 percent, and McEwen Mining Inc (NYSE: MUX), down 9 percent.

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 0.44 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 5 percent, and Gibraltar Industries Inc (NASDAQ: ROCK), down 4 percent.

popular stocks to invest in: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Lisa Levin]

    Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.

popular stocks to invest in: Myriad Genetics, Inc.(MYGN)

Advisors’ Opinion:

  • [By Cory Renauer]

    Shares of Myriad Genetics, Inc. (NASDAQ:MYGN), a DNA diagnostics specialist, dropped 61.4% last year, according todata from S&P Global Market Intelligence.Efforts to offset hereditary cancer-testing segment losses just weren’t successful enough to keep profits, and the stock, from sliding last year.

popular stocks to invest in: Axsome Therapeutics, Inc.(AXSM)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, ourUnder the Radar Moversnewsletter suggested shorting small cap clinical-stage biopharmaceutical stock Axsome Therapeutics (NASDAQ: AXSM):

  • [By Lisa Levin]

    Axsome Therapeutics Inc (NASDAQ: AXSM) shares dropped 18 percent to $3.62. Axsome Therapeutics priced 3.74 million shares at $3.74 per share.

    Shares of Canadian Solar Inc. (NASDAQ: CSIQ) were down around 11 percent to $12.10 after the company posted downbeat quarterly earnings and issued a weak forecast.

popular stocks to invest in: Ethan Allen Interiors Inc.(ETH)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a strong day for the stock market, as the Dow finished up nearly 100 points and the S&P 500 and Nasdaq both posted gains as well. Investors remained generally upbeat about the prospects for the U.S. economy in 2017, and a rise in crude oil prices helped lift the energy sector higher during the market session. Yet comments during a press conference from President-elect Donald Trump weighed on the healthcare sector, and some individual stocks took particularly hard hits. Among the worst performers were Perrigo (NYSE:PRGO), Novadaq Technologies (NASDAQ:NVDQ), and Ethan Allen Interiors (NYSE:ETH). Below, we’ll look more closely at these stocks to tell you why they did so poorly.

popular stocks to invest in: Fossil Inc.(FOSL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After running through their scenarios,Boruchow comes up with five losers from Trump’s tax plans: Carters (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil Group (FOSL) and Gap (GPS). He explains why:

  • [By Nicholas Rossolillo]

    Wearable devices are quickly becoming mainstream technology, with smartwatches and fitness trackers leading the way. You’d never know that based on the performance of traditional watchmaker Fossil Group (NASDAQ:FOSL) as the company is struggling to adapt to the changing times.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, NVIDIA (NASDAQ:NVDA) and Fossil Group(NASDAQ:FOSL) attracted heavy investor interest following their quarterly earnings reports.

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped nearly 25% Wednesday to post a new 52-week low of $13.65 after closing at $18.15 on Tuesday. The stock’s 52-week high is $36.87. Volume was more than 5 times the daily average of around 1.9 million shares. The company missed analysts’ expectations bigly this morning.

  • [By Lisa Levin]

    Fossil Group Inc (NASDAQ: FOSL) was down, falling around 21 percent to $14.32 after the company posted downbeat quarterly results and issued a weak outlook for the second quarter.

  • [By Shah Gilani]

    That’s amazingly close to the definition I’d give the once-trendy watch and accessories purveyor turned dinosaur crap retailer, Fossil Group Inc.(Nasdaq: FOSL).

penny stock message boards

Bob Rodriguez: Trump Might Be Acting; Huge Financial Crisis Still Looming

DOJ Files to Halt Thrivent Case Against DOL Fiduciary Rule

Major Risks Are Looming for US Economy: Merrills Ethan Harris

The sizable cost of elder care often catches many middle-class military families off guard. A fifth of respondents in a recent survey commissioned by First Command Financial Services said they were spending an average of $1,342 a month to care for an elderly family member, and 40% of these said the costs were more than expected.

The costs can add up. A study last year by Fidelity said a couple retiring in 2016 would need some $260,000 to cover health care costs in retirement, up 6% from the year before.

The survey found that 37% of active caregivers said the elder under their care had experienced financial abuse or exploitation…

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources STRAIGHT-THROUGH PROCESSING FOR THE FINANCIAL SERVICES INDUSTRY

STP can be described as electronically capturing and processing transactions in one pass, from the point of first ‘deal’ to final settlement.

penny stock message boards: Cherokee Inc.(CHKE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cherokee Inc (NASDAQ: CHKE) shares dropped 37 percent to $4.85 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.

  • [By Lisa Levin]

    Cherokee Inc (NASDAQ: CHKE) shares dropped 32 percent to $5.26 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.

penny stock message boards: Diamond Hill Investment Group Inc.(DHIL)

Advisors’ Opinion:

  • [By Joe Tenebruso]

    Diamond Hill Investment Group (NASDAQ:DHIL) reported first-quarter results on April 26. The investment management company is benefiting from a seemingly relentless bull market despite shifting competitive dynamics within its industry.

penny stock message boards: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

penny stock message boards: PriceSmart, Inc.(PSMT)

Advisors’ Opinion:

  • [By Monica Gerson]

    Wall Street expects PriceSmart, Inc. (NASDAQ: PSMT) to post its quarterly earnings at $0.88 per share on revenue of $775.12 million. PriceSmart shares rose 0.01 percent to $82.84 in after-hours trading.

  • [By Monica Gerson]

    PriceSmart, Inc. (NASDAQ: PSMT) is projected to post its quarterly earnings at $0.88 per share on revenue of $775.12 million.

    Ruby Tuesday, Inc. (NYSE: RT) is expected to post its quarterly earnings at $0.05 per share on revenue of $284.14 million.

  • [By Peter Graham]

    A long term performance chart shows Costco Wholesale Corporation outperforming Wal-Mart Stores, Inc (NYSE: WMT) which owns direct competitor Sams Club and small cap Latin America and the Caribbean membership shopping warehouse club PriceSmart, Inc (NASDAQ: PSMT):

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, PriceSmart (NASDAQ:PSMT) and Ryerson (NYSE:RYI)attracted heavy investor interest in the wake of their quarterly earnings reports.

penny stock message boards: SM Energy Company(SM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.

  • [By Lisa Levin]

    On Wednesday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from SM Energy Co (NYSE: SM) and W&T Offshore, Inc. (NYSE: WTI).

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Monday. Top gainers in the sector included Helix Energy Solutions Group Inc (NYSE: HLX), SM Energy Co (NYSE: SM), and Ecopetrol SA (ADR) (NYSE: EC).

equity investment

On Wednesday, our Under the Radar Moversnewsletter suggested small cap educational children’s books stock Educational Development Corporation (NASDAQ: EDUC) as a short/bearish trade:

As for Educational Development, it too has dished out several key moving average crosses within the past few days… but not bullish ones – bearish ones. And, though its choppiness has become downright reliable, that choppiness has turned net-bearish, with EDUC shares breaking under a key floor this week on huge volume. We’re really counting on the fact that the tide has turned for the worst, even if most everyone else hasn’t noticed or doesn’t care.

Our Under the Radar Moversnewsletter discussesEducational Development Corporations technical chart along with a potential short/bearish trading strategy:

equity investment: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Lisa Levin]

    Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

equity investment: Steelcase Inc.(SCS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Steelcase Inc. (NYSE: SCS) shares dropped 14 percent to $14.10 after the company reported downbeat earnings for its first quarter and issued a weak outlook for the second quarter.

  • [By Money Morning Staff Reports]

    These changes all emanate from the Ford Smart Mobility unit. Who ran that unit? New incoming Ford CEO Jim Hackett. Before joining Ford Mobility, Hackett was the corporate CEO of Steelcase Inc. (NYSE: SCS), where he transformed the company from a humdrum maker of desks to a designer of flexible, output-enhancing workspaces.

  • [By Lisa Levin]

    Steelcase Inc. (NYSE: SCS) shares shot up 5 percent to $15 as the company reported better-than-expected results for its second quarter.

    Shares of Nabriva Therapeutics plc (NASDAQ: NBRV) got a boost, shooting up 10 percent to $9.71. Nabriva Therapeutics announced a $80 million common stock offering.

  • [By Jon C. Ogg]

    Steelcase Inc. (NYSE: SCS) was raised to Strong Buy from Market Perform at Raymond James.

    SUPERVALU Inc. (NYSE: SVU) was raised to Outperform from Sector Perform at RBC Capital Markets. Shares were indicated up 6% at $3.54 on Thursday.

equity investment: Progressive Corporation (The)(PGR)

Advisors’ Opinion:

  • [By Chris Lange]

    Progressive Corp. (NYSE: PGR) is set to report its third-quarter results Tuesday morning as well. The analysts consensus estimates are $0.36 in EPS on revenue of $6.99 billion. Shares were changing hands at $48.67 on Fridays close. The consensus price target is $49.07, and the 52-week range is $30.99 to $49.75.

equity investment: Medidata Solutions, Inc.(MDSO)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Wednesday, technology shares climbed by 0.94 percent. Top gainers in the sector included Marvell Technology Group Ltd. (NASDAQ: MRVL) and Medidata Solutions Inc (NASDAQ: MDSO).

  • [By Peter Graham]

    A long term performance chart shows shares of Veeva Systems outperformingunderperforming small cap peerModel N Inc (NYSE: MODN) while mid cap Medidata Solutions (NASDAQ: MDSO) has been a huge outperformer that has just moved past its 2014 peak:

equity investment: Phillips 66 Partners LP(PSXP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    While the company continues to invest in midstream projects on its balance sheet, however, Garland reiterated that its MLP,Phillips 66 Partners (NYSE:PSXP), remains an important part of our midstream growth strategy.” Garland reaffirmed the expectation that Phillips 66 Partners will “reach its growth goal of $1.1 billion in run-rate EBITDA by the end of 2018.” That will require completing additional dropdown transactions between the two companies as well as the pursuit of new organic growth projects at the MLP.

  • [By Matthew DiLallo]

    The other highlight this quarter was the midstream business. That segment benefited from a full quarter of Phillips 66’s recently completed Freeport LPG Export Terminal as well as a turnaround in results at DCP Midstream (NYSE:DCP). After causing the company to record a loss on its investment last quarter, the DCP Midstream investment was back in the green this quarter, benefiting from hedging and lower costs. Meanwhile, the company’s other MLP investment, Phillips 66 Partners (NYSE:PSXP), delivered another steady quarter thanks to that entity’s focus on owning stable fee-based assets.

  • [By WWW.KIPLINGER.COM]

    As PSX has grown as a refining outfit, it has added midstream assets pipelines, terminals, rail lines and storage farms. Owning pipelines and gathering systems is a great way to generate cash flows. Phillips enhanced that by placing them inside of its master limited partnership, Phillip 66 Partners LP (PSXP). That way, PSX is preparing to keep its profits even when oil does inevitably rise.

equity investment: Hexcel Corporation(HXL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Hexcel Corporation (NYSE: HXL) issued a weak profit and sales forecast for 2017.
    VeriFone Systems Inc (NYSE: PAY) reported better-than-expected earnings for its fourth quarter, but issued a weak outlook for the first quarter.
    Boeing Co. (NYSE: BA) lifted its quarterly dividend by 30 percent to $1.42 per share. The company’s board also announced a a new $14 billion share buyback plans.
    Inovalon Holdings Inc (NASDAQ: INOV) cut its earnings and revenue guidance for full year 2016.